Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Looking to expand your small business? Discover various ways to explore new opportunities and drive growth effectively.
20,508 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
AMD signals a shift from pure CPUs to AI acceleration, blending edge and cloud compute. This article breaks down what...
Momentum can tilt a portfolio toward recent winners. This article explains how two Vanguard ETFs using momentum aim t...
Vanguard, the $12 trillion firm, is edging into digital assets. This move could reshape access to crypto, fees, and r...
As AI data centers surge, the race for reliable, green energy accelerates. This analysis explains how Oklo could beco...
With economic uncertainty builds rising and consumer costs stubborn, Dave Ramsey points to three core moves to weathe...
As markets swing into February 2026, a core group of performing cash stocks on Cash App are leading gains. This repor...
Real estate wealth doesn’t have to mean owning every property. This guide reveals financing-enabled ways to make bigg...
The Supreme Court's tariff ruling reshapes costs, consumer prices, and corporate margins. This guide breaks down the ...
Robert Kiyosaki says he bought more BTC, doubling down on a view that bitcoin could eventually outperform gold amid m...
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
The Dow tumbled about 800 points as fresh tariff plans and fears over AI disruption spooked investors. Analysts say p...